Follow-up on the Use of Advanced Analytics for Clinical Quality Assurance: Bootstrap Resampling to Enhance Detection of Adverse Event Under-Reporting

Björn Koneswarakantha, Yves Barmaz, Timothé Ménard () and Donato Rolo
Additional contact information
Björn Koneswarakantha: F. Hoffmann-La Roche AG
Yves Barmaz: F. Hoffmann-La Roche AG
Timothé Ménard: F. Hoffmann-La Roche AG
Donato Rolo: Roche Product Ltd.

Drug Safety, 2021, vol. 44, issue 1, No 12, 123 pages

Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40264-020-01011-5 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:drugsa:v:44:y:2021:i:1:d:10.1007_s40264-020-01011-5

Ordering information: This journal article can be ordered from
http://www.springer.com/adis/journal/40264

DOI: 10.1007/s40264-020-01011-5

Access Statistics for this article

Drug Safety is currently edited by Nitin Joshi

More articles in Drug Safety from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().